SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta Personals rollout, including ACH debit and planned fiat-payment features tied to Visa Direct and Bivo Cash, is driving attention. Bulls see the product and payment partnerships as evidence of real-world utility, while skeptics point to delays, limited usage and weak price follow-through as reasons for caution.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention as gold weaknesslinked by traders to hotter inflation, firmer rate expectations, and a stronger dollarpressures miners, with repeated technical commentary warning that the stocks correction could extend. The community is divided between that near-term downside risk and longer-term optimism about gold and mining shares amid inflation and debt concerns.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknets potential shift from an Ethereum L2 toward an independent, quantum-resistant L1 is a major focus, alongside its privacy and Bitcoin DeFi plans. Traders are split between enthusiasm for the technology and rally potential and concern about token unlocks, dilution, and sharp price swings.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc

Nasdaqs planned expansion to nearly 23-hour weekday trading is drawing attention, alongside its broader push toward tokenized and around-the-clock markets. Traders see potential for more access and exchange activity, while debating whether extended hours could also bring thinner liquidity and greater volatility.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is drawing attention as traders watch for a rebound in gold and gold miners, citing a move above its 60-day moving average and views that gold may be bottoming. Bullish traders are adding on weakness and pointing to inflation and currency concerns, while others remain cautious about golds sensitivity to interest rates and recent volatility.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Anticipation is building around TG Therapeutics Toronto MS presentations, including initial Phase 1 azer-cel findings and additional BRIUMVI data, with investors also focused on the later subcutaneous BRIUMVI Phase 3 readout and commercial growth. Traders are largely optimistic but differ on how much the early azer-cel data could mean; buyout talk remains speculation, not a confirmed development.

Aventus Network

Aventuss disclosure that an attacker exploited a code vulnerability to mint and sell AVT has focused attention on the tokens sharp drop, with thin liquidity magnifying the volatility. Traders are debating a recovery or squeeze against concerns about concentrated holdings, supply changes, and lingering confidence in the project; some also point to Aventus Clouds decentralized-compute push as a longer-term bullish narrative.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

ALM is under pressure amid broader weakness in critical-minerals stocks and macro concerns over inflation, yields and market selling. Traders are split between expecting further downside and viewing the pullback as temporary, with bullish holders pointing to Sangdongs production ramp and the tungsten supply thesis; the upcoming investor day is also drawing attention.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

Broad biotech weakness is dominating discussion, with traders attributing the selloff to rate and macro concerns, risk-off positioning, and rotation away from small-cap biotech. Some view the pullback as a buying opportunity or temporary correction, while others warn that losses could deepen; many describe individual biotech stocks as moving with the sector.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevras European CHMP re-examination of MIPLYFFA (arimoclomol) is the main focus, with traders debating whether the existing evidence can overcome the earlier refusal and when a final decision may come. Some also point to the CEOs prearranged share sale and increased short positioning amid continued share-price pressure, while others argue the sale does not signal a change in the companys outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
